STOCK TITAN

iSpecimen (ISPC) Stock News, Apr-Aug 2023

ISPC NASDAQ

iSpecimen Inc. reports developments tied to its online marketplace for human biospecimens, which connects life science researchers with a network of healthcare specimen providers. Company updates cover biospecimen sourcing for research projects, supplier-network responsiveness, direct-to-customer shipping, and marketplace technology used to match customer requests with available inventory.

Recurring news themes include AI-assisted inventory matching, SalesStack marketplace integration, respiratory and other specimen procurement, international sourcing relationships, and capital-structure actions such as the completed reverse stock split of ISPC common stock.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.80%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.93%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.45%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.26%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
-
Rhea-AI Summary

iSpecimen (Nasdaq: ISPC), a market leader in providing biospecimens for medical research, announced CEO Tracy Curley's participation at the Aegis Conference from May 2-4, 2023. Curley is scheduled to present on May 4 at 4:30 p.m. ET. The conference will be held virtually, catering to a global audience interested in biospecimen solutions for scientific research.

iSpecimen connects researchers with healthcare specimen providers through its innovative online marketplace, which enables easy access to human biospecimens necessary for medical discovery. The company utilizes proprietary technology that allows users to search for specimens across a vast network of partner healthcare organizations. This strategic engagement at the Aegis Conference highlights iSpecimen's commitment to advancing medical research through improved specimen accessibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
conferences
Rhea-AI Summary

iSpecimen (Nasdaq: ISPC) announced its financial results for the first quarter ending March 31, 2023, will be reported on May 4, 2023, before market opens. A conference call will be held at 8:30 a.m. ET that day, featuring comments from CEO Tracy Curley. Investors can join the live call by dialing +1-844-826-3033 (U.S. Toll Free) or +1-412-317-5185 (International). The conference call will also be available via audio webcast on iSpecimen's website. A replay of the call will be accessible until May 18, 2023. iSpecimen is a global online marketplace that connects researchers with healthcare specimen providers, aimed at advancing medical research through biospecimen procurement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.00%
Tags
conferences earnings

FAQ

What is the current stock price of iSpecimen (ISPC)?

iSpecimen (ISPC) last closed at $0.5961.

What is the market cap of iSpecimen (ISPC)?

The market cap of iSpecimen (ISPC) is approximately $1.5M.